Page last updated: 2024-08-25

1,2,3,4-tetrahydroquinoline and Granulocytic Leukemia

1,2,3,4-tetrahydroquinoline has been researched along with Granulocytic Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Brachet-Botineau, M; Gouilleux, F; Juen, L; Polomski, M; Prié, G; Viaud-Massuard, MC	1

Other Studies

1 other study(ies) available for 1,2,3,4-tetrahydroquinoline and Granulocytic Leukemia

Article	Year
Inhibitors Targeting STAT5 Signaling in Myeloid Leukemias: New Tetrahydroquinoline Derivatives with Improved Antileukemic Potential. ChemMedChem, 2021, 03-18, Volume: 16, Issue:6 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Leukemia, Myeloid; Molecular Structure; Quinolines; Signal Transduction; STAT5 Transcription Factor; Structure-Activity Relationship; Tumor Suppressor Proteins	2021

Article

Year

Inhibitors Targeting STAT5 Signaling in Myeloid Leukemias: New Tetrahydroquinoline Derivatives with Improved Antileukemic Potential.

ChemMedChem, 2021, 03-18, Volume: 16, Issue:6

Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Leukemia, Myeloid; Molecular Structure; Quinolines; Signal Transduction; STAT5 Transcription Factor; Structure-Activity Relationship; Tumor Suppressor Proteins

2021